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Atelosteogenesis type II (AO2) and diastrophic dysplasia (DTD) are two recessively inherited, se-
vere skeletal dysplasias caused by mutations in the SLC26A2 gene. AO2 is an invariably lethal con-
dition, while DTD patients may reach adult life, although both diseases have overlapping diagnos-
tic features. Here we report a patient with an intermediate phenotype between AO2 and DTD and 
present the successful application of preimplantation genetic diagnosis (PGD) in this situation. 
Sequencing of SLC26A2 alleles in the infant identified two compound heterozygous mutations, 
p.Arg178Ter and p.Arg279Trp, of paternal and maternal origin, respectively. At request from the 
parents, PGD was developed by haplotype mapping of parental SLC26A2 alleles in eleven five-day 
embryos. Transference to the mother was attempted twice, finally resulting in pregnancy and de-
livery of a healthy baby. This exemplifies the utility of PGD for inherited lethal conditions with a 
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plasias with prenatal manifestation. 
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Skeletal dysplasias, or osteochondrodysplasias (OCDs), comprise a vast group of genetic diseases affecting the 
formation of the skeleton [1]. About 40% of OCDs can be recognized in the prenatal period [2], and combined; 
OCDs are frequent malformations that significantly contribute to perinatal death [3]. An interesting group of re-
cessive OCDs is due to mutations in the diastrophic dysplasia sulfate transporter gene (DTDST), also known as 
SLC26A2. Conditions with this genetic basis range from severe achondrogenesis type 1B (ACG1B) and atelos-
teogenesis type II (AO2), to diastrophic dysplasia (DTD), and milder recessively inherited multiple epiphyseal 
dysplasia (rMED) and diastrophic dysplasia variant (mDTD) [4]-[6]. ACG1B and AO2 are lethal conditions [7], 
while individuals with DTD and rMED reach adult life [8]. 
AO2 comprises micromelia with adducted (“hitchhiker”) thumbs and talipes equinovarus with a wide gap 
between the first and second toes. Micrognathia, cleft palate, and small chest can also be present [9]. Shortening 
of tubular bones, humeri with U- or V-shaped distal ends, bowed radiuses and ulnae, and unossified pubic bones 
are also observed [9]. DTD usually has a similar phenotype, which may hinder the antenatal distinction between 
AO2 and severe DTD [8] [9]. This points to a transitional phenotype between these conditions, in which differ-
ent SLC26A2 alleles contribute to a spectrum of OCDs [10] [11]. 
We present a Brazilian fetus with a severe OCD diagnosed as an intermediate phenotype between AO2 and 
severe DTD by post mortem radiological investigation, the molecular diagnosis and subsequent preimplantation 
genetic diagnosis (PGD) offered to the family, leading to pregnancy and delivery of a healthy infant. 
2. Methods 
2.1. Detection of Mutations 
The SLC26A2 gene was amplified by PCR and screened for the four most common SLC26A2 mutations by re-
striction enzyme digestion and gel electrophoresis with positive and negative controls. Subsequently, selective 
fragments of the gene were analyzed by bidirectional fluorescent direct sequencing. Results have been con-
firmed in a second amplification product. Primer sequences and restriction enzymes used are listed on Table 1. 
2.2. Preimplantation Genetic Diagnosis 
The established protocol followed the guidelines of the Preimplantation Genetic Diagnosis (PGD) International 
 
Table 1. Polymersase chain reaction primers and restriction enzymes used for SLC26A2 screening.   
SLC26A2 utationa 
Reagents 
Forward primer Reverse primer Restriction enzyme 
c.−26 + 2T > C 5’-CTTCGGAGTC CGAGCGATGG-3’ 
5’-GACCCCTGAT 
CTGGGATTCT-3’ Hph I 
c.559 C > T 5’-AGGAAGCTGA ACCATCTATC-3’ 
5’-GATTCCTCAG 
ATCCCTTAGAG-3’ Dde I 
c.862 C > T 5’-CTCCATGCAA GAAATGTCAGG-3’ 
5’-TGATACAGTG 
ATAGCAAAACC-3’ Sty I 
c.1984 T > A 5’-CAACCCAATC TTAATAAAGGTG-3’ 
5’-CTAGACATTC 
TTCTATCTACC-3’ - 
a. Sequencing primer: 5’-CAACCCAATCTTAATAAAGGTG-3’. 
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Society [12]. Twenty-four oocytes were fertilized and 19 embryos were successfully produced. DNA was ex-
tracted from trophectoderm cells of eleven viable embryos on the fifth day post-fertilization. All biopsied em-
bryos were cryopreserved until transference to the mother. Whole-genome amplification was performed and 
samples were screened for SLC26A2 alleles by parental haplotype analysis, based on the mutations identified. 
As requested by the parents, 24-chromosome array-comparative genomic hybridization (aCGH) was also em-
ployed for detection of chromosomal abnormalities. 
2.3. Ethical Approval 
The individuals reported here were informed and consented with the anonymous disclosure of their medical in-
formation. This work was ethically reviewed and approved by the Institutional Review Board of Hospital de 
Clínicas de Porto Alegre. 
3. Results 
Recently, a non-consanguineous couple (32-year-old father and 30-year-old mother) of Portuguese ancestry was 
referred to our Institution during their second pregnancy due to recurrence of detection of a severe OCD. Their 
previous pregnancy ended at 16 weeks of gestation, after short fetal long bones and trunk constriction were de-
tected. During the second pregnancy, ultrasonography identified again very short long bones and pregnancy 
ended at 17 weeks. Postnatal physical examination revealed a female fetus with severely shortened limbs and 
fingers with hitchhiker thumbs, varus deformity of lower limbs, talipes equinovarus with a wide gap between 
first and second toes, relative macrocephaly, midface hypoplasia, micrognathia, and short trunk (Figure 1(a)). 
Babygram showed narrowing of upper thorax, thin ribs, round ilia, and short long bones and metacarpals 
(Figure 1(b)). These findings were very suggestive of either AO2 or DTD. 
Sequencing of the mother-father-child trio characterized the fetus as a compound heterozygote for two known 
pathogenic SLC26A2 point mutations, c.559C > T (p.Arg178Ter) of paternal, and c.862 C > T (p.Arg279Trp) of 
maternal origins (Figure 1(c) and Figure 2). This genotype has been previously observed and associated with 
AO2 and DTD [9], and the 17-week fetus presented indeed characteristic radiographic findings of both disord-
ers. 
A PGD protocol was elected by the family for a subsequent pregnancy. Upon the establishment of a PGD 
protocol, haplotype reconstructions identified only two embryos carrying both wild type SLC26A2 alleles 
(Table 2). These were firstly transferred to the mother, but no pregnancy developed. Of the other 9 samples, 
seven carried just one of the two pathogenic alleles, and only five were chromosomally balanced. The parents 
opted for the implantation of two heterozygous carrier embryos, and this second attempt resulted in pregnancy 
and delivery of a healthy infant, although the baby was not postnatally screened for SLC26A2 mutations. 
4. Discussion 
In the present study, the evaluated fetus had clinical findings compatible with both AO2 and severe DTD. In fact, 
the skeletal abnormalities reported here are strikingly similar to those identified in patients reported by Macías- 
Gomez and colleagues (2004) [10] and Maeda and colleagues [11], who were also diagnosed with an interme-
diate AO2/DTD condition. 
In SLC26A2, the p.Arg279Trp mutation impairs protein activity by approximately 50%, when compared to 
the wild-type transporter [13]. Additionally, p.Arg178Ter is the second most common mutation found in patients 
of the DTDST spectrum [4]. In Xenopus laevis oocytes, it was shown that p.Arg178Ter behaves almost as a null 
allele, practically abolishing the protein’s sulfate transport activity [14]. 
The substitution p.Arg279Trp has been found in AO2 mostly in compound heterozygosity with p.Arg178Ter 
or with another null allele [7] [10] [13] [15], and the p.Arg178Ter + p.Arg279Trp genotype has been identified 
in almost half of the patients with AO2, as well as in 20% of patients with DTD diagnosed at the Lausanne Mo-
lecular Pediatrics laboratory (L. Mittaz-Crettol, personal communication). Barbosa and colleagues (2011) iden-
tified compound heterozygosity for p.Arg178Ter and p.Arg279Trp in seven Portuguese patients diagnosed with 
classical DTD, and commented on the phenotypic overlap due to SLC26A2 mutations [8]. Another group re-
ported both mutations in an infant with clinical and skeletal findings suggestive of a severe variant of DTD or a 
mild form of AO2 [10]. These observations reinforce the notion that the same SLC26A2 mutations may not 




Figure 1. Phenotype of the fetus at 17 weeks of gestation. A: Fetus ap-
pearance upon necropsy. Note the short trunk and limbs and the bowing of 
lower limbs with club feet. Hands with the characteristic “hitchhiker” 
thumb and feet with a wide gap between the first and second toes are also 
present. B: Whole-body radiography of the fetus, revealing short long 
bones, thoracic constriction, thin ribs, and round ilia with unossified pubis. 
C: SLC26A2 sequencing of the mother-father-child trio. Electropherograms 
depict heterozygous peaks corresponding to the c.559 C > T substitution 
(p.Arg178Ter) of paternal origin, and to the c.882 C > T substitution 
(p.Arg279Trp) of maternal origin.                                   
 
 
Figure 2. Restriction enzyme digestion of PCR products amplified from the 
DNA of the fetus. Top legend: P stands for patient, wt for a wild type control, 
het for a heterozygous control sample and homo for a homozygous control sam-
ple for the given mutation. Side legend: wt stands for the non-digested allele. 
The allele being digested is presented with the description of the mutation that 
gives rise to the new restriction site.                                      
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Table 2. Preimplantation genetic diagnosis for AO2/DTD and embryo selection.                        
Sample 
Embryo characteristics 
Inferred allelesa aCGH result Interpretation Fate of embryo 
2 p.Arg178Ter wtc 45, XX; -2 Heterozygous carrier (paternal mutant allele); chromosome 2 monosomy Not used 
5 p.Arg178Ter/wt 45, XX; -17 Heterozygous carrier (paternal mutant allele); chromosome 17 monosomy Not used 
6 wt/p.Arg279Trp 46, XY Heterozygous carrier  (maternal mutant allele) 
Transferred attempt #2, 
healthy infant born 
7 p.Arg178Ter/wt 46, XX Heterozygous carrier  (paternal mutant allele) Transferred attempt #2 
9 wt/p.Arg279Trp 46, XY Heterozygous carrier  (maternal mutant allele) Cryopreserved 
10 wt/wt 46, XX Wild type at the SLC26A2 locus Transferred attempt #1 
11 wt/p.Arg279Trp 46, XY Heterozygous carrier  (maternal mutant allele) Cryopreserved 
13 wt/p.Arg279Trp 46, XX Heterozygous carrier  (maternal mutant allele) Cryopreserved 
14 p.Arg178Ter/ p.Arg279Trp NT
b Compound heterozygous mutant  (maternal and paternal mutant alleles) Not used 
17 p.Arg178Ter/ p.Arg279Trp NT 
Compound heterozygous mutant  
(maternal and paternal mutant alleles) Not used 
19 wt/wt 46, XY Wild type at the SLC26A2 locus Transferred attempt #1 
a. Alleles from embryos were imputed from parental haplotypes. b. NT: not tested. c. wt: wildtype allele, without any of the pa-
rental mutations, as inferred by haplotype analysis. 
 
always translate into a single, characteristic phenotype, implying genetic and/or environmental factors influen-
cing sulfate transport activity and clinical outcome. 
5. Conclusion 
This report exemplifies the growing application of PGD for severe monogenic diseases [16]. To the best of our 
knowledge, this is one of the first published descriptions on the application of PGD for a recessive lethal skeletal 
dysplasia with phenotypic characteristics between AO2 and DTD, leading to the successful live birth of a 
healthy infant. This exemplifies a growing trend in the medical genetics field, especially for the management of 
lethal recurrent Mendelian traits with substantial risk of recurrence. 
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